Hsp16.3 of mycobacterium tuberculosis in exosomes as a biomarker of tuberculosis

Can Huang1, Liping Pan2, Xiaoli Shen1

  • 1CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, People's Republic of China.

Insights

Researchers found that the Mycobacterium tuberculosis (MTB) protein Hsp16.3 is present in exosomes from infected cells and tuberculosis patients, suggesting it could be a novel biomarker for diagnosing tuberculosis.

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Microbiology

Background:

  • Exosomes are cell-derived vesicles containing proteins and nucleic acids.
  • Mycobacterium tuberculosis (MTB) produces the small heat shock protein Hsp16.3.
  • Identifying reliable tuberculosis biomarkers is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the presence and distribution of Hsp16.3 protein in exosomes.
  • To evaluate the potential of Hsp16.3 in exosomes as a biomarker for tuberculosis diagnosis.

Main Methods:

  • Overexpression of Hsp16.3 protein in cells.
  • Infection of U937 cells with MTB and analysis of secreted exosomes.
  • Detection of Hsp16.3 protein in exosomes from blood of tuberculosis patients.

Main Results:

  • Overexpressed Hsp16.3 protein was efficiently packaged into exosomes.
  • MTB-infected U937 cells secreted excessive amounts of Hsp16.3 in exosomes.
  • Significant levels of Hsp16.3 protein were found in blood exosomes of tuberculosis patients.

Conclusions:

  • Hsp16.3 protein can be effectively packaged into exosomes.
  • Exosomal Hsp16.3 levels are elevated in MTB infection and tuberculosis.
  • This research indicates a potential for an exosome-based biomarker for tuberculosis diagnosis.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
257
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
568
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
451
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
305